Evidence map›Paper›PMID 25946402›Full record

ReviewJournal of neurochemistry2016

Immune dysfunction in Niemann-Pick disease type C.

Nick Platt, Annelise O Speak, Alexandria Colaco, James Gray, David A Smith, Ian M Williams, Kerri-Lee Wallom, Frances M Platt

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of neurochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Endo-lysosomal dysfunction and neuronal-glial crosstalk in Niemann-Pick type C disease.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nick PlattDepartment of Pharmacology, University of Oxford, Oxford, UK.
Annelise O SpeakDepartment of Pharmacology, University of Oxford, Oxford, UK.
Alexandria ColacoDepartment of Pharmacology, University of Oxford, Oxford, UK.
James GrayDepartment of Pharmacology, University of Oxford, Oxford, UK.
David A SmithDepartment of Pharmacology, University of Oxford, Oxford, UK.
Ian M WilliamsDepartment of Pharmacology, University of Oxford, Oxford, UK.
Kerri-Lee WallomDepartment of Pharmacology, University of Oxford, Oxford, UK.
Frances M PlattDepartment of Pharmacology, University of Oxford, Oxford, UK.
University of Oxford · GB

Funding

Targetting the Niemann-Pick disease type C cellular pathway as a novel approach tR21AI102166 · NIAID · UNIVERSITY OF OXFORD · PI PLATT, FRANCES MARY, PLATT, NICHOLAS · 2012 to 2013
$296k
Medical Research Council G0700851Medical Research Council MR/K015338/1NIAID NIH HHS 1R21AI102166NIAID NIH HHS R21 AI102166
6 · The paper itself

Abstract

Lysosomal storage diseases are inherited monogenic disorders in which lysosome function is compromised. Although individually very rare, they occur at a collective frequency of approximately one in five thousand live births and usually have catastrophic consequences for health. The lysosomal storage diseases Niemann-Pick disease type C (NPC) is caused by mutations predominantly in the lysosomal integral membrane protein NPC1 and clinically presents as a progressive neurodegenerative disorder. In this article we review data that demonstrate significant dysregulation of innate immunity in NPC, which occurs both in peripheral organs and the CNS. In particular pro-inflammatory responses promote disease progression and anti-inflammatory drugs provide benefit in animal models of the disease and are an attractive target for clinical intervention in this disorder. Niemann-Pick disease type C is a rare, devastating, inherited lysosomal storage disease with a unique cellular phenotype characterized by lysosomal accumulation of sphingosine, various glycosphingolipids and cholesterol and a reduction in lysosomal calcium. In this review we highlight the impact of the disease on innate immune activities in both the central nervous system (CNS) and peripheral tissues and discuss their contributions to pathology and the underlying mechanisms.

Indexed as

AnimalsHumansImmunity, CellularKiller Cells, NaturalNiemann-Pick Disease, Type Ccytokineinflammationlysosomal storage diseaselysosomemicroglianeurodegenerationNiemann Pick type C

Identifiers

PMID25946402
PMCPMC4833189
OpenAlexW1564327509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.